JAK1 and colon carcinoma: Butyrate reduced JAK2 phosphorylation, JAK1 phosphorylation, STAT1 phosphorylation and its nuclear translocation and DNA binding activity in IFN-γ-activated HCT116 or Hke-3 colon carcinoma cell lines.